These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 23916257)
1. Discovery and SAR of 5-aminooctahydrocyclopentapyrrole-3a-carboxamides as potent CCR2 antagonists. Cai C; McComsey DF; Hou C; O'Neill JC; Opas E; McKenney S; Johnson D; Sui Z Bioorg Med Chem Lett; 2014 Feb; 24(4):1239-42. PubMed ID: 23916257 [TBL] [Abstract][Full Text] [Related]
2. Conformational studies of 3-amino-1-alkyl-cyclopentane carboxamide CCR2 antagonists leading to new spirocyclic antagonists. Pasternak A; Goble SD; Doss GA; Tsou NN; Butora G; Vicario PP; Ayala JM; Struthers M; Demartino JA; Mills SG; Yang L Bioorg Med Chem Lett; 2008 Feb; 18(4):1374-7. PubMed ID: 18215519 [TBL] [Abstract][Full Text] [Related]
3. Novel 2-aminooctahydrocyclopentalene-3a-carboxamides as potent CCR2 antagonists. Cai C; Kang FA; Hou C; O'Neill JC; Opas E; McKenney S; Johnson D; Sui Z Bioorg Med Chem Lett; 2013 Jan; 23(1):351-4. PubMed ID: 23182090 [TBL] [Abstract][Full Text] [Related]
4. Structure-kinetic relationships--an overlooked parameter in hit-to-lead optimization: a case of cyclopentylamines as chemokine receptor 2 antagonists. Vilums M; Zweemer AJ; Yu Z; de Vries H; Hillger JM; Wapenaar H; Bollen IA; Barmare F; Gross R; Clemens J; Krenitsky P; Brussee J; Stamos D; Saunders J; Heitman LH; Ijzerman AP J Med Chem; 2013 Oct; 56(19):7706-14. PubMed ID: 24028535 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of (4-Arylpiperidin-1-yl)cyclopentanecarboxamides As High-Affinity and Long-Residence-Time Antagonists for the CCR2 Receptor. Vilums M; Zweemer AJ; Dilanchian A; van Veldhoven JP; de Vries H; Brussee J; Saunders J; Stamos D; Heitman LH; IJzerman AP ChemMedChem; 2015 Jul; 10(7):1249-58. PubMed ID: 26033831 [TBL] [Abstract][Full Text] [Related]
6. The discovery of potent, orally bioavailable pyrazolo and triazolopyrimidine CXCR2 receptor antagonists. Porter DW; Bradley M; Brown Z; Canova R; Charlton S; Cox B; Hunt P; Kolarik D; Lewis S; O'Connor D; Reilly J; Spanka C; Tedaldi L; Watson SJ; Wermuth R; Press NJ Bioorg Med Chem Lett; 2014 Jan; 24(1):72-6. PubMed ID: 24332493 [TBL] [Abstract][Full Text] [Related]
7. Discovery of 3-piperidinyl-1-cyclopentanecarboxamide as a novel scaffold for highly potent CC chemokine receptor 2 antagonists. Yang L; Butora G; Jiao RX; Pasternak A; Zhou C; Parsons WH; Mills SG; Vicario PP; Ayala JM; Cascieri MA; MacCoss M J Med Chem; 2007 May; 50(11):2609-11. PubMed ID: 17461566 [TBL] [Abstract][Full Text] [Related]
8. When structure-affinity relationships meet structure-kinetics relationships: 3-((Inden-1-yl)amino)-1-isopropyl-cyclopentane-1-carboxamides as CCR2 antagonists. Vilums M; Zweemer AJ; Barmare F; van der Gracht AM; Bleeker DC; Yu Z; de Vries H; Gross R; Clemens J; Krenitsky P; Brussee J; Stamos D; Saunders J; Heitman LH; IJzerman AP Eur J Med Chem; 2015 Mar; 93():121-34. PubMed ID: 25666912 [TBL] [Abstract][Full Text] [Related]
9. Overcoming hERG activity in the discovery of a series of 4-azetidinyl-1-aryl-cyclohexanes as CCR2 antagonists. Zhang X; Hufnagel H; Markotan T; Lanter J; Cai C; Hou C; Singer M; Opas E; McKenney S; Crysler C; Johnson D; Sui Z Bioorg Med Chem Lett; 2011 Sep; 21(18):5577-82. PubMed ID: 21783361 [TBL] [Abstract][Full Text] [Related]
10. Identification of a sulfonamide series of CCR2 antagonists. Peace S; Philp J; Brooks C; Piercy V; Moores K; Smethurst C; Watson S; Gaines S; Zippoli M; Mookherjee C; Ife R Bioorg Med Chem Lett; 2010 Jul; 20(13):3961-4. PubMed ID: 20627722 [TBL] [Abstract][Full Text] [Related]
11. Discovery of trisubstituted cyclohexanes as potent CC chemokine receptor 2 (CCR2) antagonists. Cherney RJ; Brogan JB; Mo R; Lo YC; Yang G; Miller PB; Scherle PA; Molino BF; Carter PH; Decicco CP Bioorg Med Chem Lett; 2009 Feb; 19(3):597-601. PubMed ID: 19131247 [TBL] [Abstract][Full Text] [Related]
12. 3-Amino-1-alkyl-cyclopentane carboxamides as small molecule antagonists of the human and murine CC chemokine receptor 2. Butora G; Jiao R; Parsons WH; Vicario PP; Jin H; Ayala JM; Cascieri MA; Yang L Bioorg Med Chem Lett; 2007 Jul; 17(13):3636-41. PubMed ID: 17482462 [TBL] [Abstract][Full Text] [Related]
13. Discovery and synthesis of cyclohexenyl derivatives as modulators of CC chemokine receptor 2 activity. Brown GD; Shi Q; Delucca GV; Batt DG; Galella MA; Cvijic ME; Liu RQ; Qiu F; Zhao Q; Barrish JC; Carter PH Bioorg Med Chem Lett; 2016 Jan; 26(2):662-666. PubMed ID: 26631321 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationship of 7-azaindole piperidine derivatives as CCR2 antagonists. Xia M; Hou C; DeMong D; Pollack S; Pan M; Singer M; Matheis M; Murray W; Cavender D; Wachter M Bioorg Med Chem Lett; 2008 Dec; 18(24):6468-70. PubMed ID: 18990568 [TBL] [Abstract][Full Text] [Related]
15. The discovery of novel cyclohexylamide CCR2 antagonists. Lanter JC; Markotan TP; Zhang X; Subasinghe N; Kang FA; Hou C; Singer M; Opas E; McKenney S; Crysler C; Johnson D; Molloy CJ; Sui Z Bioorg Med Chem Lett; 2011 Dec; 21(24):7496-501. PubMed ID: 22061641 [TBL] [Abstract][Full Text] [Related]
16. Capped diaminopropionamide-glycine dipeptides are inhibitors of CC chemokine receptor 2 (CCR2). Carter PH; Brown GD; Friedrich SR; Cherney RJ; Tebben AJ; Lo YC; Yang G; Jezak H; Solomon KA; Scherle PA; Decicco CP Bioorg Med Chem Lett; 2007 Oct; 17(19):5455-61. PubMed ID: 17720492 [TBL] [Abstract][Full Text] [Related]